DONAFENIB
DONAFENIB Uses, Dosage, Side Effects, Food Interaction and all others data.
DONAFENIB is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated Thyroid Cancer).
Trade Name | DONAFENIB |
Generic | CM-4307 |
CM-4307 Other Names | DONAFENIB |
Type | |
Formula | C21H16ClF3N4O3 |
Weight | Average: 467.85 Monoisotopic: 467.1051328 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here DONAFENIB